The effects of two weeks of repeated low-dose allergen exposure on sputum eosinophilic and neutrophilic inflammation in atopic asthma: protection by inhaled steroids?

J. de Kluijver, C. E. Evertse, J. A. Schrumpf, H. van der Veen, K. F. Rabe, J. H. J. M. van Krieken, P. S. Hiemstra, P. J. Sterk (Leiden, Nijmegen, The Netherlands)

Source: Annual Congress 2001 - Mechanisms of allergen immunotherapy
Session: Mechanisms of allergen immunotherapy
Session type: Oral Presentation
Number: 3234
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. de Kluijver, C. E. Evertse, J. A. Schrumpf, H. van der Veen, K. F. Rabe, J. H. J. M. van Krieken, P. S. Hiemstra, P. J. Sterk (Leiden, Nijmegen, The Netherlands). The effects of two weeks of repeated low-dose allergen exposure on sputum eosinophilic and neutrophilic inflammation in atopic asthma: protection by inhaled steroids?. Eur Respir J 2001; 16: Suppl. 31, 3234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchial cell infiltrate after two weeks, repeated low-dose allergen exposure in atopic asthma: protection by inhaled steroids?
Source: Eur Respir J 2002; 20: Suppl. 38, 588s
Year: 2002

Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002



Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 569s
Year: 2002

Reduced late asthmatic response by repeated low-dose allergen exposure
Source: Eur Respir J 2001; 17: 872-880
Year: 2001



Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids
Source: Annual Congress 2003 - Current issues on wheezing in infancy
Year: 2003


Airway autoimmunity and response to a 14-day course of oral corticosteroids in patients with severe eosinophilic asthma
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020


To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Repeated inhaled airway allergen challenge model in asthma
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Bronchodilator effect of deep inhalation, airway inflammation, and allergen avoidance in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 383s
Year: 2003

Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 258s
Year: 2006

Tolerance to the protective effect of salmeterol on allergen challenge in mild untreated asthmatics and in moderate asthmatics on inhaled corticosteroid treatment
Source: Eur Respir J 2001; 18: Suppl. 33, 103s
Year: 2001

Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 135s
Year: 2005

A single nasal allergen challenge increases induced sputum inflammatory parameters in non-asthmatic patients with seasonal allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001

Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2004; 24: Suppl. 48, 595s
Year: 2004

Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 734s
Year: 2005

The effect of single dose montelukast and desloratadine, alone and in combination, on the allergen induced late airway response in atopic asthma
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008